Samrat Pharmachem has enclosed a copy of notice convening Board Meeting on Friday, the 14th day of November, 2025 for considering and taking on record the Un-Audited Financial Results of the Company under Indian Accounting Standards (Ind-As) for the quarter ended September 30, 2025. Further as per Regulation 46 of SEBI (Listing Obligations and Disclosure Requirements) regulations, 2015 (LODR), notice of the Board meeting would be made available on the website of the Company at www.samratpharmachem.com.
The above information is a part of company’s filings submitted to BSE.
